What Is CJC-1295 Ipamorelin No DAC?

CJC-1295 ipamorelin no DAC is a two-peptide stack that pairs a short-acting growth hormone-releasing hormone (GHRH) analog with ipamorelin, a growth hormone secretagogue. The no-DAC label means the CJC-1295 molecule is missing the Drug Affinity Complex, so it clears the body in roughly 30 minutes instead of staying active for days. Neither peptide is FDA-approved for human use in the United States, and both are sold as research chemicals.

That is the cjc-1295 ipamorelin no dac meaning in plain terms: a fast-clearing GHRH analog plus a ghrelin-mimetic, usually blended into a single vial. Some suppliers list the exact same product as cjc-1295 no dac + ipamorelin, so those two labels describe identical contents.

The No-DAC Label, Explained

The Drug Affinity Complex is a small chemical addition that lets CJC-1295 bind to albumin in the bloodstream. That binding is why CJC-1295 with DAC stays active for roughly 6 to 8 days and produces a steady rise in growth hormone and IGF-1.

Remove the DAC and you get Mod GRF 1-29, a peptide with a half-life of about 30 minutes. The signal becomes sharper and more pulsatile, which is closer to how the body releases growth hormone naturally during deep sleep.

How CJC-1295 No DAC and Ipamorelin Work Together

The two peptides act on different receptors. CJC-1295 no DAC binds GHRH receptors on pituitary cells, while ipamorelin activates the ghrelin receptor, also called GHS-R1a. Because the pathways are separate, they can amplify the same growth hormone pulse instead of competing with each other.

For a broader look at the pair without the no-DAC detail, see what is cjc-1295 ipamorelin — the same receptor logic applies here.

Ipamorelin is often described as the most selective of the older growth hormone secretagogues. In the studies that measured it, ipamorelin triggered less cortisol and prolactin release than GHRP-2 or GHRP-6.

Reported Benefits vs. What the Evidence Shows

Discussions of cjc-1295 ipamorelin no dac benefits usually center on sleep quality, recovery, joint comfort, and lean body composition. Those claims rest mostly on user reports rather than controlled human trials.

Human research on CJC-1295 with DAC is limited to a few small studies from the 2000s, and the no-DAC version has even less clinical data. There is no large randomized trial of the CJC-1295 no DAC plus ipamorelin combination in healthy adults.

• Growth hormone and IGF-1: the most consistently measured effect is a temporary rise in circulating GH and IGF-1 after injection.
• Body composition: reported in user logs, but not established for this blend in controlled trials.
• Sleep: frequently mentioned anecdotally, and the mechanism is plausible because most GH is released during deep sleep.
• Recovery and joints: commonly claimed and rarely documented in peer-reviewed data.

Threads on cjc-1295 no dac ipamorelin reddit are full of personal logs, and they can be useful for spotting side effects. Anecdotes are not evidence that a peptide works.

Dosing Ranges People Talk About

Vials sold as a cjc-1295 no dac ipamorelin 10mg blend dosage product typically contain 5 mg of each peptide. The numbers below come from online community discussions and older research protocols, not from FDA-reviewed labeling.

Those figures are not medical advice and are not a dosing recommendation. Peptide dosing depends on body weight, goals, and health status, and self-dosing carries real risk.

Safety, Side Effects, and Legal Status

Reported side effects include injection-site irritation, flushing, headache, increased hunger, water retention, and tingling or numb hands. Some users describe lethargy or grogginess after dosing.

More serious concerns include persistently elevated IGF-1, changes in blood sugar regulation, and possible stimulation of existing tumors. People with active cancer, uncontrolled diabetes, or who are pregnant should not use these compounds.

CJC-1295 and ipamorelin are not FDA-approved for human use. In the US they are sold as research chemicals, which means purity, sterility, and actual peptide content are not guaranteed by any regulator.

Anyone asking what is ipamorelin cjc 1295 should understand that the pair is a growth-hormone-releasing research combination, not an approved therapy.

Before You Consider It

Talk with a physician or endocrinologist before using any peptide. Useful questions include baseline IGF-1, fasting glucose, and whether a growth hormone secretagogue interacts with your medications or medical history.

If you are researching the topic, prioritize primary sources such as PubMed over vendor marketing pages. Reputable sellers publish third-party certificates of analysis, but a COA does not make a product legal or safe for human use.